Fagron NV provides pharmaceutical compounding services to hospitals, pharmacies, clinics, and patients worldwide. The company operates through four segments: Fagron Speciality Pharma Services, Fagron Trademarks, Fagron Essentials, and HL Technology. The Fagron Speciality Pharma Services segment prepares customized medication in sterile and non-sterile compounding facilities in Europe, the United States, Colombia, and South Africa. The Fagron Trademarks segment develops concepts, vehicles, and formulations for pharmaceutical compounding developed by Fagron. The Fagron Essentials segment reconditions and distributes pharmaceutical raw materials, supplies, and equipment that pharmacists need to prepare medication in the pharmacy. The HL Technology segment develops and produces precision components and orthopedic tools for dental and medical industry. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

13.75 EUR
As of 01/30/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Index country:  Belgium
Country of incorporation:  Belgium
IPO date:  10/05/2007
Stock exchange:    Nyse Euronext - Euronext
Exchange country:   Belgium
Market cap:   0 EUR
Current dividend yield:   0.00%
Sedol:      B281L72

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy